Geoffrey Straub Martha
Net Worth
Last updated:
What is Geoffrey Straub Martha net worth?
The estimated net worth of Mr. Geoffrey Straub Martha is at least $56,699,025 as of 2 Aug 2024. He owns shares worth $12,897,020 as insider, has earned $6,992,005 from insider trading and has received compensation worth at least $36,810,000 in Medtronic plc.
What is the salary of Geoffrey Straub Martha?
Mr. Geoffrey Straub Martha salary is $4,090,000 per year as Chairman & Chief Executive Officer in Medtronic plc.
How old is Geoffrey Straub Martha?
Mr. Geoffrey Straub Martha is 55 years old, born in 1970.
What stocks does Geoffrey Straub Martha currently own?
As insider, Mr. Geoffrey Straub Martha owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Medtronic plc (MDT) | Chairman & Chief Executive Officer | 143,348 | $89.97 | $12,897,020 |
What does Medtronic plc do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Geoffrey Straub Martha insider trading
Medtronic plc
Mr. Geoffrey Straub Martha has made 8 insider trades between 2016-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 49,799 units of MDT stock on 24 Sep 2018. As of 2 Aug 2024 he still owns at least 143,348 units of MDT stock.
Medtronic key executives
Medtronic plc executives and other stock owners filed with the SEC:
- Dr. Richard E. Kuntz M.D., M.Sc. (68) Senior Vice President and Chief Medical & Scientific Officer
- Mr. Bradley E. Lerman (69) Senior Vice President, Gen. Counsel & Corporation Sec.
- Mr. Geoffrey Straub Martha (55) Chairman & Chief Executive Officer
- Mr. Robert John White (62) Executive Vice President & Pres of Medical Surgical Portfolio
- Ms. Karen L. Parkhill (60) EVice President, Chief Financial Officer, IT & Enterprise Excellence